Rock Edwin
- SEC CIK
- 0001945417
No open-market purchases or sales filed in the past year.
Current role at each company
- CBIO Crescent Biopharma, Inc.Chief Medical Officeras of Jun 24, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rock Edwin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2024 (view filing)4:29 PM ET | Jun 20-21 | 4 days | Rock EdwinChief Medical Officer | PPurchase | +305.0K | $0.2584 | +$78.8K | +81.2%680.4K after | 2 lots |
| Sep 25, 2023 (view filing) | Sep 21-22 | 4 days | Rock EdwinChief Medical Officer | PPurchase | +65.4K | $1.38 | +$90.3K | +21.1%375.4K after | 2 lots |
| Dec 27, 2022 (view filing) | Dec 22 | 5 days | Rock EdwinChief Medical Officer | PPurchase | +110.0K | $2.25 | +$247.5K | +55.0%310.0K after | |
| Nov 16, 2022 (view filing) | Nov 14-15 | 2 days | Rock EdwinChief Medical Officer | PPurchase | +200.0K | $1.55 | +$309.0K | New position200.0K after | 2 lots |